Every SEC Form 3/4/5 on record for this filer (CIK 1996637) — 1 issuer, 7 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PCRX | Pacira BioSciences, Inc. | Director | 2023-10-11 → 2026-06-12 | 9 | −$14,565 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PCRX | 2025-08-07 | Sell | 4,912 | $23.67 | $116,267 | 11,393 |
| PCRX | 2024-08-16 | Buy | 1,512 | $13.25 | $20,034 | 10,142 |
| PCRX | 2024-08-12 | Buy | 3,400 | $12.01 | $40,834 | 8,630 |
| PCRX | 2024-08-12 | Buy | 3,400 | $12.01 | $40,834 | 8,630 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.